Cargando…
Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study
Critically ill patients with coronavirus diseases 2019 (COVID-19) are of grave concern. Those patients usually underwent a stage of excessive inflammation before developing acute respiratory distress syndrome. In this study, we test the hypothesis that short-term, low-to-moderate-dose corticosteroid...
Autores principales: | Li, Yang, Zhou, Xian, Li, Tao, Chan, Shiji, Yu, Yiqi, Ai, Jing-Wen, Zhang, Haocheng, Sun, Feng, Zhang, Qiran, Zhu, Lei, Shao, Lingyun, Xu, Bin, Zhang, Wenhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473313/ https://www.ncbi.nlm.nih.gov/pubmed/32795143 http://dx.doi.org/10.1080/22221751.2020.1807885 |
Ejemplares similares
-
Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study
por: Shi, Jichan, et al.
Publicado: (2020) -
Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern
por: Ai, Jingwen, et al.
Publicado: (2021) -
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study
por: Ai, Jingwen, et al.
Publicado: (2022) -
The Longitudinal Force Measurement of CWR Tracks with Hetero-Cladding FBG Sensors: A Proof of Concept
por: Shao, Li-Yang, et al.
Publicado: (2016) -
Corticosteroid plus β(2)-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis
por: Wang, Gang, et al.
Publicado: (2017)